MIDDLETOWN, NJ - During a Trenton 11-30-20 press conference, the imminent, 'warp speed' release of multiple COVID-19 vaccines was discussed. The speed and success of the Trumps vaccine development partnerships with the public and private sector has been acclaimed from both Republicans and even local Democrats, now including New Jersey Governor Phil Murphy.
According to Governor Murphy, "We had a White House call on Monday afternoon, and we'll have another one after this (news conference)... but the conversations have been productive." stated Murphy.
"Incredible progress has been made. Hats off to the folks in their battling through this in the current (Trump) administration as well as the private sector players. The decades of investment in public health in our country are all the contributing factors - but you have to call it as it is - it's pretty impressive, the vaccine development."
"This is an area that is bright." said Murphy.
Murphy went on to discuss the vaccines and said, "We can both laud the progress that has been made and continues to be made and also, let's acknowledge that we are not in the end zone yet."
The vaccine development has fascinated those in the field. According to a November 30th article in ScienceMag, "Moderna and the Pfizer/BioNTech collaboration say their vaccines worked to about the same degree in all different groups, ethnicities, and genders.That equal success is vital information for bodies trying to prioritize the use of the new vaccines, such as an advisory panel to the Centers for Disease Control and Prevention (CDC) that is meeting tomorrow. The committee’s recommendations influence CDC’s decisions about vaccine prioritization, but individual states come up with their own guidelines."
The article went on to say, "Moderna received $1 billion from the U.S. government’s Operation Warp Speed to help develop its mRNA vaccine. (Pfizer passed on such development money, but has signed an advanced purchase order for its vaccine with Warp Speed.) Moderna CEO Stéphane Bancel says all of the federal money went toward staging the clinical trials, and that without it, progress surely would have been delayed. Investors in May contributed another $1.3 billion to help the young company, which has no products on the market, build facilities to produce its vaccine."
Murphy summed it up during the news conference on vaccine development, "this is an area that is bright."
According to the companies, Moderna plans to provide the U.S. government with about 20 million doses by the end of December, and Pfizer says it should have 50 million doses to split between the United States and other countries.
Get your local news delivered to your inbox for FREE each day. Sign up to get all the news as it happens at www.TAPinto.net/enews